메뉴 건너뛰기
Regenerative Medicine
Volumn 7, Issue 6 SUPPL., 2012, Pages 78-81
Regulation, manufacturing and building industry consensus
Author keywords

[No Author keywords available]
Indexed keywords

ACCREDITATION; BIOPROCESS; BUILDING INDUSTRY; CLINICAL DEVELOPMENT PLAN; CONSENSUS DEVELOPMENT; GOOD MANUFACTURING PRACTICE; HEALTH CARE INDUSTRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MARKETING; MESENCHYMAL STROMA CELL; ORGANIZATIONAL EFFICIENCY; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; REGENERATIVE MEDICINE; REIMBURSEMENT; REVIEW; SCALE UP;
EID: 84870698863     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.98     Document Type: Review
Times cited : (6)
References (12)
  • 1
    • 79953732758 scopus 로고    scopus 로고
    • Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    • Dominici M, LeBlanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 9, 301-302 (2007).
    • (2007) Cytotherapy , vol.9 , pp. 301-302
    • Dominici, M.1    Leblanc, K.2    Mueller, I.3
  • 2
    • 84870715621 scopus 로고    scopus 로고
    • Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
    • Horwitz E, Le Blanc K, Dominici M et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2005).
    • (2005) Cytotherapy , vol.8 , pp. 315-317
    • Horwitz, E.1    Le Blanc, K.2    Dominici, M.3
  • 3
    • 60549090781 scopus 로고    scopus 로고
    • Stem cell therapies as an emerging paradigm in stroke (steps): Bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke
    • Stem Cell Therapies as an Emerging Paradigm in Stroke Participants.
    • Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 40(2), 5102515 (2009).
    • (2009) Stroke , vol.40 , Issue.2 , pp. 5102515
  • 4
    • 70349576348 scopus 로고    scopus 로고
    • Towards MSC in solid organ transplant: 2008 position paper of the MISOT study group
    • Dahlke M, Hoogduijn M, Eggenhofer E et al. Towards MSC in solid organ transplant: 2008 position paper of the MISOT study group. Transplantation 88(5), 614-619 (2009).
    • (2009) Transplantation , vol.88 , Issue.5 , pp. 614-619
    • Dahlke, M.1    Hoogduijn, M.2    Eggenhofer, E.3
  • 5
    • 80054774332 scopus 로고    scopus 로고
    • Commercialization of trials for peripheral arterial disease
    • Sherman W, Mazouz C, Deans R, Patel A. Commercialization of trials for peripheral arterial disease. Cytotherapy 13(10), 1157-1161 (2011).
    • (2011) Cytotherapy , vol.13 , Issue.10 , pp. 1157-1161
    • Sherman, W.1    Mazouz, C.2    Deans, R.3    Patel, A.4
  • 8
    • 84870704991 scopus 로고    scopus 로고
    • Engineering and Physical Sciences Research Council. www.epsrc.ac.uk/ Pages/default.aspx
  • 9
    • 84870678135 scopus 로고    scopus 로고
    • Foundation for the Accreditation of Cellular Therapy
    • Foundation for the Accreditation of Cellular Therapy. www.factwebsite.org/
  • 10
    • 84870704724 scopus 로고    scopus 로고
    • International Society for Cellular Therapy. www.celltherapysociety.org/
  • 11
    • 84870696116 scopus 로고    scopus 로고
    • London Regenerative Medicine Network. www.lrmn.com/
  • 12
    • 84870698516 scopus 로고    scopus 로고
    • Society for Biological Engineers. www.aiche.org/sbe

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.